| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Muparfostat sodium | PI-88 | Phase 3 Clinical | Australian National University | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Liver Neoplasms; Lung Neoplasms; Melanoma; Neoplasms; Prostatic Neoplasms; Skin Melanoma; Solid tumours | Details |
| TTHX-1114 | TTHX-1114; NM-141; NM141; TTHX1114 | Phase 2 Clinical | Florida State University | Corneal Diseases; Corneal Dystrophies, Hereditary; Fuchs' Endothelial Dystrophy; Vascular Diseases | Details |